Omega Healthcare Investors Reports 8-K Filing

TL;DR

OHI filed an 8-K on 9/30, reporting material agreements, obligations, and Reg FD disclosures.

AI Summary

Omega Healthcare Investors, Inc. filed an 8-K on October 1, 2025, reporting on events as of September 30, 2025. The filing indicates the entry into and termination of material definitive agreements, the creation of direct financial obligations, and includes Regulation FD disclosures and financial statements. Specific details regarding the nature of these agreements or obligations are not provided in this excerpt.

Why It Matters

This 8-K filing signals significant corporate actions by Omega Healthcare Investors, Inc., potentially impacting its financial obligations and agreements.

Risk Assessment

Risk Level: medium — The filing involves material definitive agreements and financial obligations, which can carry inherent risks depending on their specifics.

Key Players & Entities

• OMEGA HEALTHCARE INVESTORS, INC. (company) — Registrant
• September 30, 2025 (date) — Date of earliest event reported
• October 1, 2025 (date) — Filing date
• 303 International Circle, Suite 200 (location) — Principal business address
• Hunt Valley, Maryland 21030 (location) — Principal business address

FAQ

Key Financial Figures

• $0.10 — ange on which registered Common Stock, $0.10 par value OHI New York Stock Exchan
• $2.3 billion — ") entered into a new senior unsecured $2.3 billion credit facility, comprised of a $2.0 bi
• $2.0 billion — billion credit facility, comprised of a $2.0 billion multicurrency revolving credit facility
• $300.0 million — y (" Revolving Credit Facility ") and a $300.0 million delayed draw term loan facility (the "
• $600 billion — e Currencies ") or U.S. Dollars, with a $600 billion sublimit for loans in Alternative Curre
• $75.0 m — ar instruments in an amount of at least $75.0 million, individually or in the aggregate
• $3.0 b — mmitments under the Credit Agreement to $3.0 billion, by requesting an increase in the
• $428.5 million — nder the Credit Facility, and Omega had $428.5 million in borrowings outstanding under the Ter
• $1.45 billion — t described in Item 1.01, replacing the $1.45 billion senior unsecured revolving credit facil

Filing Documents

• ohi-20250930x8k.htm (8-K) — 50KB
• ohi-20250930xex10d1.htm (EX-10.1) — 1620KB
• ohi-20250930xex10d2.htm (EX-10.2) — 1244KB
• ohi-20250930xex99d1.htm (EX-99.1) — 20KB
• ohi-20250930xex99d1001.jpg (GRAPHIC) — 8KB
• 0000888491-25-000031.txt ( ) — 3498KB
• ohi-20250930.xsd (EX-101.SCH) — 4KB
• ohi-20250930_def.xml (EX-101.DEF) — 3KB
• ohi-20250930_lab.xml (EX-101.LAB) — 13KB
• ohi-20250930_pre.xml (EX-101.PRE) — 10KB
• ohi-20250930x8k_htm.xml (XML) — 5KB

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement. Omega Credit Agreement On September 30, 2025, Omega Healthcare Investors, Inc. (" Omega ") entered into a new senior unsecured $2.3 billion credit facility, comprised of a $2.0 billion multicurrency revolving credit facility (" Revolving Credit Facility ") and a $300.0 million delayed draw term loan facility (the " DDTL Credit Facility " and together with the Revolving Credit Facility, the " Credit Facility "), replacing its previous senior unsecured multicurrency revolving credit facility (see Item 1.02). The Credit Facility is being provided pursuant to an Amended and Restated Credit Agreement, dated as of September 30, 2025 (the " Credit Agreement "), among Omega, as a borrower, OHI UK Healthcare Properties Ltd., as a U.K. borrower (the " UK Borrower "), certain of Omega's subsidiaries identified in the Credit Agreement, as guarantors, a syndicate of financial institutions, as lenders (together with other lenders from time to time becoming signatory to the Credit Agreement, as lenders, the " Omega Lenders "), and Bank of America, N.A., as administrative agent, which amends and restates Omega's Credit Agreement, dated as of August 30, 2021. The Revolving Credit Facility may be drawn in Euros, British Pounds Sterling, Canadian Dollars (collectively, " Alternative Currencies ") or U.S. Dollars, with a $600 billion sublimit for loans in Alternative Currencies, and the DDTL Credit Facility may be drawn in U.S. Dollars. The Revolving Credit Facility matures on September 28, 2029, subject to Omega's option to extend such maturity date for two, six-month periods. The DDTL Credit Facility is available to be drawn for a period of up to 180 days after closing. The DDTL Credit Facility does not amortize and matures on September 29, 2028, subject to Omega's option to extend such maturity date for two, twelve-month periods. Exercise of each such extension option is subject to compliance with a notice requirement and o

02 Termination of a Material Definitive Agreement

Item 1.02 Termination of a Material Definitive Agreement. On September 30, 2025, Omega entered into the Credit Agreement described in Item 1.01, replacing the $1.45 billion senior unsecured revolving credit facility (the " 2021 Revolving Credit Facility "), and amending and restating the related Credit Agreement, dated as of April 30, 2021 (as amended, " 2021 Omega Credit Agreement "), by and among Omega, as borrower, OHI LP, as guarantor, a syndicate of financial institutions, as lenders, and Bank of America, N.A., as administrative agent. The 2021 Revolving Credit Facility was scheduled to expire, unless extended, on October 30, 2025. Omega terminated the 2021 Revolving Credit Facility in connection with the effectiveness of the Credit Facility. Omega did not experience any material early termination penalties due to the termination of the 2021 Revolving Credit Facility.

03

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information under Item 1.01 is incorporated herein by reference.

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. On September 30, 2025, Omega issued a press release announcing its entry into the Credit Agreement and the First Amendment. The information set forth in this Item 7.01 and in Exhibit 99.1 is furnished pursuant to Item 7.01–Regulation FD Disclosure and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section nor shall the information be deemed incorporated by reference in any filing of Omega.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (a) Exhibits: Exhibit No. Description 10.1 Amended and Restated Credit Agreement, dated as of September 30, 2025, by and among Omega Healthcare Investors, Inc., as a borrower, OHI UK Healthcare Properties Ltd., as a U.K. borrower, certain of Omega's subsidiaries identified therein, as guarantors, a syndicate of financial institutions, as lenders, and Bank of America, N.A., as administrative agent. 10.2 First Amendment to Credit Agreement dated September 30, 2025, amending the Credit Agreement dated August 8, 2023, by and among Omega, as borrower, certain of Omega's subsidiaries identified from time to time therein, as guarantors, a syndicate of financial institutions, as lenders, and Bank of America, N.A., as administrative agent. 99.1 Press Release issued by Omega, dated September 30, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. OMEGA HEALTHCARE INVESTORS, INC. Dated: October 1, 2025 By: /s/ Robert O. Stephenson Robert O. Stephenson Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR